Skip to main content
. 2012 Mar 24;35(4):327–334. doi: 10.1159/000337151

Table 3.

Risk factors for dialysis-requiring acute kidney injury among HIV-infected veterans, stratified by antiretroviral treatment era

Characteristic 1986–1995
1996–2006
HR (95% CI) p value HR (95 % CI) p value
Age, years
  • <35 (lowest quartile)

Reference Reference
  • 35–40

  • 1.28 (0.91–1.81)

0.160
  • 1.43 (0.98–2.10)

0.067
  • 41–47

  • 1.07 (0.73–1.56)

0.742
  • 1.39 (0.96–2.02)

0.082
  • ≥48 (highest quartile)

  • 0.76 (0.49–1.16)

0.204
  • 1.40 (0.97–2.02)

0.071
Race
  • White

Reference Reference
  • Black

  • 4.89 (2.08–11.48)

<0.001
  • 1.69 (1.31–2.18)

<0.001
Hypertension
  • 1.85 (1.44–2.36)

<0.001
Diabetes
  • 3.60 (2.30–5.63)

<0.001
  • 1.38 (1.06–1.80)

0.015
Cardiovascular disease
  • 1.53 (0.80–2.94)

0.197
  • 1.93 (1.52–2.45)

<0.001
Hepatitis C virus
  • 2.87 (1.66–4.96)

<0.001
  • 1.37 (1.09–1.72)

0.007
CD4 count, cells/mm3
  • >500

Reference Reference
  • 350–499

  • 5.40 (1.16–25.03)

0.031
  • 0.96 (0.56–1.66)

0.890
  • 200–350

  • 4.44 (0.97–20.34)

0.055
  • 1.93 (1.23–3.00)

0.004
  • 0–199

  • 7.12 (1.73–29.36)

0.007
  • 4.21 (2.85–6.20)

<0.001
Viral load, copies/ml
  • 0–499

Reference Reference
  • 500–29,999

  • 1.09 (0.80–1.49)

0.569
  • 30,000–100,000

  • 1.23 (0.83–1.82)

0.305
  • ≥100,000

  • 2.22 (1.57–3.15)

<0.001
Body mass index
  • <18.5

  • 1.30 (0.27–6.14)

0.743
  • 1.21 (0.79–1.85)

0.375
  • 18.5–25.0

Reference Reference
  • ≥25.0

  • 2.07 (0.75–5.72)

0.163
  • 0.73 (0.57–0.94)

0.013
Albumin, mg/dl
  • ≥4.3 (highest quartile)

Reference Reference
  • 4.0–4.3

  • 0.63 (0.10–3.76)

0.609
  • 3.74 (1.05–13.25)

0.041
  • 3.7–4.0

  • 1.71 (0.42–6.86)

0.451
  • 4.44 (1.29–15.26)

0.018
  • <3.7 (lowest quartile)

  • 5.50 (1.67–18.07)

0.005
  • 15.68 (4.95–49.71)

<0.001
eGFR <60 ml/min/1.73 m2 15.12 (8.56–26.73) <0.001 18.87 (13.07–27.22) <0.001
Proteinuria
  • 5.25 (2.60–10.62)

<0.001
  • 4.16 (2.59–6.69)

<0.001

Multivariate model includes factors with a p value <0.05 in univariate analysis. All factors in table 1 were evaluated as candidate predictors. All estimates are adjusted for receipt of antiretroviral therapy.